{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:06:23Z","timestamp":1761663983554,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.aohep.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T12:24:30Z","timestamp":1571919870000},"page":"161-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America"],"prefix":"10.1016","volume":"19","author":[{"given":"Luis","family":"Viola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Colombato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Cheinquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Bugarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Tatsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Carvalho-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Roblero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Varon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Holguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Torres-Ibarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma M.","family":"P\u00e9rez-R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.09.006_bib0110","doi-asserted-by":"crossref","unstructured":"Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161\u201376.","DOI":"10.1016\/S2468-1253(16)30181-9"},{"key":"10.1016\/j.aohep.2019.09.006_bib0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1471-2334-14-218","article-title":"Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Argentine blood donors","volume":"14","author":"Flichman","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.006_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1478-3231.2011.02538.x","article-title":"Trends and projections of hepatitis C virus epidemiology in Latin America","volume":"31","author":"Kershenobich","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2019.09.006_bib0125","first-page":"35","article-title":"Hepatitis C in Argentina: epidemiology and treatment","volume":"6","author":"Gaite","year":"2014","journal-title":"Hepat Med"},{"key":"10.1016\/j.aohep.2019.09.006_bib0130","first-page":"79","article-title":"Hepatitic C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals","volume":"10","author":"Trinks","year":"2017","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.aohep.2019.09.006_bib0135","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.3748\/wjg.v22.i22.5137","article-title":"Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America","volume":"22","author":"Panduro","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-13-60","article-title":"Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study","volume":"13","author":"Pereira","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.006_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1665-2681(19)31719-3","article-title":"Epidemiology of HCV infection in Latin America","volume":"9","author":"M\u00e9ndez-S\u00e1nchez","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMoa0805062","article-title":"Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C","volume":"360","author":"Rodriguez-Torres","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2019.09.006_bib0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cgh.2008.02.036","article-title":"Latinos and chronic hepatitis C: a singular population","volume":"6","author":"Rodr\u00edguez-Torres","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0160","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1572-0241.2006.00682.x","article-title":"More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis","volume":"101","author":"Verma","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0165","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.aohep.2019.09.006_bib0170","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jmv.25033","article-title":"Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: a real world study","volume":"90","author":"Marciano","year":"2018","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bjid.2018.06.004","article-title":"Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil","volume":"22","author":"Holzmann","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.aohep.2019.09.006_bib0180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00038-015-0708-5","article-title":"Hepatitis C in key populations in Latin America and the Caribbean: systemic review and meta-analysis","volume":"60","author":"Alonso","year":"2015","journal-title":"Int J Public Health"},{"key":"10.1016\/j.aohep.2019.09.006_bib0185","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/jmv.24816","article-title":"Ombitasvir\/paritaprevir\/ritonavir\/dasabuvir\u00b1ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America","volume":"89","author":"Mendizabal","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.aohep.2019.09.006_bib0190","first-page":"275","article-title":"The Mexican consensus on the treatment of hepatitis C","volume":"83","author":"Aiza-Haddad","year":"2018","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.aohep.2019.09.006_bib0195","unstructured":"Ministry of Health of Brazil. Clinical protocol and therapeutic guidelines for hepatitis C and coinfections; 2017. Available at: http:\/\/www.aids.gov.br\/pt-br\/pub\/2017\/protocolo-clinico-e-diretrizes-terapeuticas-para-hepatite-c-e-coinfeccoes [accessed 10.08.19]."},{"key":"10.1016\/j.aohep.2019.09.006_bib0200","unstructured":"Argentine Association for the Study of Liver Diseases. Recommendations for the Treatment of Chronic Hepatitis C Virus: Indications for Treatment 2018; 2018. Available at: https:\/\/www.aaeeh.org.ar\/images\/CONSENSOSYGUIAS\/Guias-XX18---ltima.pdf [accessed 10.08.19]."},{"key":"10.1016\/j.aohep.2019.09.006_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cld.771","article-title":"Which strategies should be implemented in Latin America to eradicate hepatitis C virus by 2030?","volume":"13","author":"Ridruejo","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.aohep.2019.09.006_bib0210","article-title":"Challenges and strategies for access to treatment of hepatitis C in Latin America","author":"Kershenobich","year":"2019","journal-title":"InTechOpen"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:12Z","timestamp":1761647952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119322574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1665268119322574"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.006","relation":{},"ISSN":["1665-2681"],"issn-type":[{"type":"print","value":"1665-2681"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}